Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1245.50

-24.30 (-1.91%)

< Home < Back

USFDA completes audit at Dr. Reddy's subsidiary in Hyderabad

Date: 23-03-2019

USFDA has completed audit of R&D facility of Aurigene Discovery Technologies, a wholly owned subsidiary of Dr. Reddy's Laboratories, situated at Miyapur, Hyderabad. No FDA 483 was issued at the end of inspection.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.